Skip to content

Clinical trials

Phase 2 Brain Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 2 Country / region: Netherlands Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20041
20112
20141
20153
20162
20201
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting3
Terminated3
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
Children's Oncology Group3
Maastricht University Medical Center2
University Medical Center Groningen2
AbbVie1
Eli Lilly and Company1
Hoffmann-La Roche1
Karyopharm Therapeutics Inc1
Leiden University Medical Center1
Maastricht Radiation Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms20
Central Nervous System Neoplasms7
Glioblastoma7
Glioma5
Astrocytoma4
Gliosarcoma4
Oligodendroglioma4
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms2
Melanoma2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.